Frequency Of Relapse in Bipolar Affective Disorder MTI Ayub Teaching Hospital Abbottabad Khyber Pakhtunkhwa Pakistan.
DOI:
https://doi.org/10.69980/ajpr.v28i5.804Keywords:
Relapse, Bipolar Affective Disorder, Depression, Mania/Hypomania, Mixed Affective Episode, Treatment Adherence, Psychopathology, Mental Health Care.Abstract
Bipolar Affective Disorder BPAD is a severe mental illness marked by recurrent episodes of mania/hypomania, depression, or mixed states. It affects 2-4% of the global population, making it the sixth leading cause of disability worldwide. The Global Burden of Disease Study 2013 estimated that 48.8 million people suffered from BPAD, with a higher prevalence in women and individuals aged 25–29 years. BPAD is associated with elevated suicide risk, psychiatric comorbidities, and substantial social and economic burdens. The treatment of BPAD is essential to prevent severe complications, including relapse. Objective: To determine the frequency of relapse in patients diagnosed with bipolar affective disorder at Ayub Teaching Hospital, Abbottabad. Study Design: A cross-sectional descriptive study was conducted to assess the frequency of relapse in patients with bipolar affective disorder. The study was carried out at the Department of Psychiatry, Ayub Teaching Hospital, Abbottabad, Pakistan, from July 1st to December 31st, 2022. The study included 80 patients aged between 18–60 years diagnosed with bipolar affective disorder, both male and female, under outpatient follow-up treatment for at least one month. Patients with schizophrenia and those unable to communicate were excluded. Methods: Data collection involved structured proformas that recorded demographic details, bipolar disorder subtype, and relapse status. The relapse was defined as the return of full syndrome criteria for mania, mixed episodes, or depression following any duration of remission. The collected data were analyzed using SPSS version 10.0, with descriptive statistics, including frequencies, percentages, and mean ± standard deviation for quantitative variables. Results: Demographics: The mean age of patients was 33.96±13.97 years, with a mean weight of 55.50±7.88 kg. 55% of the patients were male, and 45% were female. Bipolar Affective Disorder Subtypes: 45% of patients had depression, 22.5% had mania, 27.5% had mixed episodes, and 5% had hypomania. Relapse Frequency: 68.8% of the patients experienced relapse, while 31.3% did not. Age Distribution: 56.3% of patients were under 30 years, and 43.8% were aged 30 years or older. Gender and Bipolar Subtypes: Males showed higher rates of mania and mixed episodes, while females were more likely to have depression. Relapse by Gender: Males had a relapse rate of 70.5%, while females had a relapse rate of 66.7%. Relapse by Age Group: 73.3% of patients below 30 years relapsed, compared to 62.9% in those aged 30 and above. Conclusions: The study found a high relapse rate of 68.8% among bipolar disorder patients. Treatment adherence and effective management of psychopathology are crucial for preventing relapse. The study highlights the importance of focusing on medication adherence and psychoeducation. Further research is needed to explore mental health care and relapse prevention in low-income countries to improve outcomes for bipolar disorder patients.References
1. Ashok, A. H., T. R. Marques, S. Jauhar, M. M. Nour, G. M. Goodwin, and A. H. Young. "The Dopamine Hypothesis of Bipolar Affective Disorder: The State of the Art and Implications for Treatment." Molecular Psychiatry 22 (2017): 666-79.
2. Andrade-González, N., L. Álvarez-Cadenas, J. Saiz-Ruiz, and G. Lahera. "Initial and Relapse Prodromes in Adult Patients with Episodes of Bipolar Disorder: A Systematic Review." European Psychiatry 63 (2020): e12.
3. Syan, S. K., M. Smith, B. N. Frey, R. Remtulla, F. Kapczinski, G. B. C. Hall, and L. Minuzzi. "Resting-State Functional Connectivity in Individuals with Bipolar Disorder during Clinical Remission: A Systematic Review." Journal of Psychiatry and Neuroscience 43 (2018): 298-316.
4. López-Muñoz, F., W. W. Shen, P. D'Ocon, A. Romero, and C. Álamo. "A History of the Pharmacological Treatment of Bipolar Disorder." International Journal of Molecular Sciences 19 (2018): 2143.
5. Amare, A. T., K. O. Schubert, L. Hou, S. R. Clark, S. Papiol, U. Heilbronner, et al. "Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes with Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study." JAMA Psychiatry 75 (2018): 65-74.
6. Sparding, T., E. Pålsson, E. Joas, S. Hansen, and M. Landén. "Personality Traits in Bipolar Disorder and Influence on Outcome." BMC Psychiatry 17 (2017): 159.
7. Belete, H., T. Ali, and G. Legas. "Relapse and Clinical Characteristics of Patients with Bipolar Disorders in Central Ethiopia: A Cross-Sectional Study." Psychiatry Journal 2020 (2020): 8986014.
8. Kessing, L. V., K. Munkholm, M. Faurholt-Jepsen, K. W. Miskowiak, L. B. Nielsen, R. Frikke-Schmidt, et al. "The Bipolar Illness Onset Study: Research Protocol for the BIO Cohort Study." BMJ Open 7 (2017): e015462.
9. Sam, S. P., A. Nisha, and P. J. Varghese. "Stressful Life Events and Relapse in Bipolar Affective Disorder: A Cross-Sectional Study from a Tertiary Care Center of Southern India." Indian Journal of Psychological Medicine 41 (2019): 61-67.
10. Wesseloo, R., A. M. Kamperman, T. Munk-Olsen, V. J. Pop, S. A. Kushner, and V. Bergink. "Risk of Postpartum Relapse in Bipolar Disorder and Postpartum Psychosis: A Systematic Review and Meta-Analysis." American Journal of Psychiatry 173 (2016): 117-27.
11. Zhang, D., L. Cheng, Y. Qian, N. Alliey-Rodriguez, J. R. Kelsoe, T. Greenwood, et al. "Singleton Deletions throughout the Genome Increase Risk of Bipolar Disorder." Molecular Psychiatry 14 (2009): 376-80.
12. Price, A. L., and G. R. Marzani-Nissen. "Bipolar Disorders: A Review." American Family Physician 85 (2012): 483-93.
13. Ketter, T. A. "Diagnostic Features, Prevalence, and Impact of Bipolar Disorder." Journal of Clinical Psychiatry 71 (2010): e14.
14. Edvardsen, J., S. Torgersen, E. Røysamb, S. Lygren, I. Skre, S. Onstad, et al. "Heritability of Bipolar Spectrum Disorders: Unity or Heterogeneity?" Journal of Affective Disorders 106 (2008): 229-40.
15. Berrettini, W. H., T. N. Ferraro, L. R. Goldin, D. R. Weeks, S. E. Detera-Wadleigh, J. I. Nurnberger Jr, et al. "Chromosome 18 DNA Markers and Manic-Depressive Illness: Evidence for a Susceptibility Gene." Proceedings of the National Academy of Sciences of the United States of America 91 (1994): 5918-21.
16. Reich, T., P. J. Clayton, and G. Winokur. "Family History Studies: V. The Genetics of Mania." American Journal of Psychiatry 125 (1969): 1358-69.
17. Lin, P. I., M. G. McInnis, J. B. Potash, V. L. Willour, D. F. Mackinnon, K. Miao, et al. "Assessment of the Effect of Age at Onset on Linkage to Bipolar Disorder: Evidence on Chromosomes 18p and 21q." American Journal of Human Genetics 77 (2005): 545-55.
18. McQuillin, A., N. J. Bass, G. Kalsi, J. Lawrence, V. Puri, K. Choudhury, et al. "Fine Mapping of a Susceptibility Locus for Bipolar and Genetically Related Unipolar Affective Disorders, to a Region Containing the C21ORF29 and TRPM2 Genes on Chromosome 21q22.3." Molecular Psychiatry 11 (2006): 134-42.
19. Ekholm, J. M., T. Kieseppä, T. Hiekkalinna, T. Partonen, T. Paunio, M. Perola, et al. "Evidence of Susceptibility Loci on 4q32 and 16p12 for bipolar disorder." Human Molecular Genetics 12 (2003): 1907-15.
20. Abou Jamra, R., R. Fuerst, R. Kaneva, G. Orozco Diaz, F. Rivas, F. Mayoral, et al. "The First Genomewide Interaction and Locus-Heterogeneity Linkage Scan in Bipolar Affective Disorder: Strong Evidence of Epistatic Effects Between Loci on Chromosomes 2q and 6q." American Journal of Human Genetics 81 (2007): 974-86.
21. Kelsoe, J. R., M. A. Spence, E. Loetscher, M. Foguet, A. D. Sadovnick, R. A. Remick, et al. "A Genome Survey Indicates a Possible Susceptibility Locus for Bipolar Disorder on Chromosome 22." Proceedings of the National Academy of Sciences of the United States of America 98 (2001): 585-90.
22. Kakiuchi, C., K. Iwamoto, M. Ishiwata, M. Bundo, T. Kasahara, I. Kusumi, et al. "Impaired Feedback Regulation of XBP1 as a Genetic Risk Factor for Bipolar Disorder." Nature Genetics 35 (2003): 171-75
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
